FOLR1 and cancer: In a cohort of 58 gastric cancer patients, immunohistochemical analysis was used to assess the expression of FOLR1 and FOLR2 and correlate these findings with various clinical and pathological variables such as age, gender, cancer stage, tumor site, liver involvement, and histological type (Table 3).